Amyloid+ (n = 183) | CN (n = 93) | MCI (n = 60) | Dementia (n = 30) | p value |
Age in years | 75.67 (7.25) | 76.16 (6.82) | 76.95 (7.90) | 0.692 |
Sex (male/female) | 40/53 | 35/25 | 14/16 | 0.175 |
Years of education | 16.59 (2.30) | 15.78 (2.73) | 16.1 (2.34) | 0.132 |
MMSE score | 28.83 (1.48)b,c | 27.2 (2.32)a,c | 22.27 (3.85)a,b | < 0.001 |
ADAS13 score | 12.88 (5.27)b,c | 19.44 (6.92)a,c | 32.50 (9.32)a,b | < 0.001 |
ADNI-MEM score | 0.95 (0.56)b,c | 0.13 (0.60)a,c | − 0.73 (0.73)a,b | < 0.001 |
Amyloid-PET CL | 62.10 (32.54)c | 75.72 (37.44) | 88.30 (36.61)a | < 0.001 |
Global Tau-PET SUVR | 1.13 (0.09)b,c | 1.22 (0.18)a,c | 1.38 (0.36)a,b | < 0.001 |
Braak0/BraakI+/BraakI–IV+/BraakI–VI+/Braakatypical+ | 68/16/6/1/2 | 22/14/13/8/3 | 6/4/6/13/1 | < 0.001 |
Mean cognitive follow-up in years | 2.03 (0.68) | 1.88 (0.87) | 1.67 (0.73) | 0.072 |
Amyloid− (n = 213) | CN (n = 146) | MCI (n = 62) | Dementia (n = 5) | p value |
Age in years | 72.76 (6.87) b | 75.47 (8.60) a | 71.22 (7.45) | 0.045 |
Sex (female/male) | 60/86 | 39/23 | 3/2 | 0.014 |
Years of education | 16.95 (2.42)c | 16.18 (3.00) | 14 (2.83)a | 0.011 |
MMSE score | 29.21 (0.98)b,c | 28.56 (1.72)a,c | 24.4 (1.14)a,b | < 0.001 |
ADAS13 score | 11.16 (4.29)b,c | 16.19 (5.43)a,c | 30.07 (4.39)a,b | < 0.001 |
ADNI-MEM score | 1.10 (0.60)b,c | 0.60 (0.56)a,c | − 0.61 (0.59)a,b | < 0.001 |
Amyloid-PET CL | 5.60 (8.82)b | − 0.72 (12.34)a | − 3.03 (8.87) | < 0.001 |
Global Tau-PET SUVR | 1.09 (0.07) | 1.08 (0.08) | 1.08 (0.07) | 0.811 |
Braak0/BraakI+/BraakI–IV+/BraakI–VI+/Braakatypical+ | 137/5/1/2/1 | 56/4/1/0/1 | 4/1/0/0/0 | 0.718 |
Mean cognitive follow-up in years | 2.18 (0.62) | 2.01 (0.92) | 1.53 (0.58) | 0.056 |